NCT03477383View on ClinicalTrials.gov

A New Biomarker for the Non-invasive Diagnosis of Rejection After Heart Transplantation

CompletedOBSERVATIONAL
Enrollment

134

Participants

Timeline

Start Date

March 1, 2016

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
Heart Transplant Rejection
Interventions
DIAGNOSTIC_TEST

donor-derived cell-free DNA (dd-cfDNA)

Measurement of dd-cfDNA and comparison against grade of rejection as measured by endomyocardial biopsy, taken simultaneously

Trial Locations (4)

17176

Pediatric Heart Center, Karolinska University Hospital, Stockholm

22241

Pediatric Heart Center, Skåne University Hospital, Lund

41234

Transplantation Center, Sahlgrenska University Hospital, Gothenburg

41685

Pediatric Heart Center, The Queen Silvia Children's Hospital, Sahlgrenska University Hospital, Gothenburg

All Listed Sponsors
collaborator

Lund University Hospital

OTHER

collaborator

Karolinska University Hospital

OTHER

lead

Vastra Gotaland Region

OTHER_GOV

NCT03477383 - A New Biomarker for the Non-invasive Diagnosis of Rejection After Heart Transplantation | Biotech Hunter | Biotech Hunter